Find similar content

Source channel @githubtrending · Post #15036 · Aug 8

#other#agent#ai#artificial_intelligence#autogpt#autonomous_agents#awesome#babyagi#copilot#gpt#gpt_4#gpt_engineer#openai#python Codeium is a free AI-powered coding assistant that helps you write code faster and better by providing real-time autocomplete suggestions, generating code from natural language, explaining code, and assisting with refactoring. It supports over 70 programming languages and integrates with many popular IDEs like Visual Studio Code. Codeium learns from your coding style and project context to offer relevant suggestions, saving you time and reducing errors. It also includes a chat feature to answer coding questions instantly, so you don’t need to switch to a browser for help. This boosts your productivity and code quality efficiently. https://github.com/e2b-dev/awesome-ai-agents

Hashtags

#other #agent #ai #artificial_intelligence #autogpt #autonomous_agents #awesome #babyagi #copilot #gpt #gpt_4 #gpt_engineer #openai #python

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment